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ABSTRACT
Eosinophilic gastroenteritis is an inflammatory gastrointestinal disease characterized by eosinophilic infiltration of the digestive tract. 
The subserous type is the rarest form and diagnosis is challenging because the symptoms are heterogeneous and endoscopy may be 
non-diagnostic. The authors describe the clinical case of a 41-year-old female patient who was diagnosed with subserous eosinophilic 
gastroenteritis. This case highlights the importance of clinical suspicion of eosinophilic gastroenteritis in patients in the third to fifth decades 
of life with gastrointestinal symptoms, ascites and eosinophilia.
LEARNING POINTS
•  Subserous eosinophilic gastroenteritis is an uncommon inflammatory gastrointestinal disease with a challenging diagnosis because the 
symptoms are heterogeneous and endoscopy may be non-diagnostic.
• The diagnosis should be suspected in the presence of gastrointestinal symptoms, and peripheral eosinophilia is confirmed by the 
presence of eosinophilic infiltration of the gastrointestinal tract or ascites with a predominance of eosinophils, after the exclusion of 
other causes of eosinophilia.
• Automated cell counting analysis of the ascitic fluid can wrongly identify eosinophils as neutrophils, which can delay the diagnosis.
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INTRODUCTION
Eosinophilic gastrointestinal disorders are a family of uncommon diseases and include eosinophilic oesophagitis, gastritis and enterocolitis. 
Disease typically occurs during the third to fifth decades of life[1]. 
The pathogenesis is not well understood, but there may be an allergic component. Histologically, disease is characterized by infiltration of 
the digestive tract tissues by eosinophils[1].
Clinical manifestations depend on the location, extent and layers of digestive tract involved[1]. In disease restricted to the mucosa, symptoms 
are non-specific and abdominal pain, nausea, vomiting, diarrhoea, weight loss and malabsorption syndrome can occur depending on the area 
involved. Disease with muscular involvement is mainly characterized by symptoms of intestinal obstruction. 
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000586 European Journal of Case Reports in Internal Medicine © EFIM 2017
When there is involvement of the serous layer, the clinical presentation may include isolated ascites or ascites combined with symptoms 
described in mucosal or muscular disease. Peripheral eosinophil counts are generally increased but may be normal in 20% of cases[1]. 
We describe a clinical case of eosinophilic gastroenteritis with isolated involvement of the subserous layer.
CASE REPORT
A 41-year-old female patient was admitted through the emergency department with increased abdominal volume, anorexia, general 
malaise and watery diarrhoea for 15 days before admission. The patient had a past history of autoimmune hypothyroidism medicated with 
levothyroxine 0.1 mg/day. She had no history of allergies, alcohol intake, ingestion of well water, contact with animals or recent trips abroad.
On initial evaluation the patient was conscious and vital signs were normal. Abdominal examination showed ascites with no palpable masses 
or organomegaly. No peripheral oedema, stigmata of chronic liver disease or adenopathy were present. Blood tests revealed leucocytosis 
(12,560/µl) with 6,280 neutrophils/µl and 3,454 eosinophils/µl, C-reactive protein of 2.04 mg/dl, a sedimentation rate of 6 mm and albumin 
of 3.3 g/dl (Table 1). Clear liquid obtained from diagnostic paracentesis revealed an albumin of 3 g/dl and a calculated serum albumin gradient 
(SAG) below 1.1 g/dl, suggesting that portal hypertension was not the cause of the ascites. The ascitic fluid (10mL) contained 15,646 cells 
of which 1,846 were leucocytes (neutrophils 75%, monocytes 20%, lymphocytes 5%, no description of eosinophils), total proteins 5.0 g/dl, 
glucose 92 mg/dl, LDH 140 IU/l, ADA 10.4 IU/l and amylase 20 IU/l. Abdominal computed axial tomography showed ascites, thickening of 
the walls of the stomach, duodenum and jejunum, and a suspected nodular pancreatic lesion (Fig. 1).
PARAMETER VALUE REFERENCE VALUE PARAMETER VALUE
Haemoglobin (g/dl) 15.0 11.8–15.8 Serum IgG/IgA/IgM Normal
Mean corpuscular volume (fl) 84.4 80.4–96.4 HIV/ANA/ANCAs Negative
Leucocytes (/µl) 12.56 4.0–10.0 Anti-transglutaminase/ 
antigliadin antibodies
Negative
Neutrophils (/µl) 6,280 1,800–7,700 Fasciola, Histoplasma, 
Entamoeba, Toxocara canis
serologies
Negative
Eosinophils (/µl) 3,454 <500 Urine analysis Normal
Platelets (×109/l) 321 150–400
Creatinine (mg/dl) 0.75 0.6–1.0 Ascitic fluid analysis
Sodium (mmol/l) 141 136–145 Cells (/µl) 15,646
Potassium (mmol/l) 3.8 3.5–5.1 Leucocytes (/µl) 1,846
C-reactive protein 2.04 0.01–0.82 Neutrophils (%) 75
Sedimentation rate (mm/h) 6 4–10 Monocytes(%) 20
Albumin (g/dl) 3.3 3.5–5.5 Lymphocytes (%) 5
Thyroid stimulating hormone 
(µIU/l)
4.42 0.35–4.94 Erythrocytes (/µl) 13,800
Aspartate aminotransferase 
(IU/l)
18 8–35 Albumin (g/dl) 3.0
Alanine transaminase (IU/l) 24 7–45 Total proteins (g/dl) 5.0
Alkaline phosphatase (IU/l) 68 30–120 Lactate dehydrogenase 
(IU/l)
140
Gamma glutamyl transferase
(IU/l)
31 <38 ADA (IU/l) 10.4
Total bilirubin (mg/dl) 0.41 0.3–1.2 Glucose (mg/dl) 92
Lactate dehydrogenase (IU/l) 315 125–220 Amylase (IU/l) 20
Prothrombin time (sec) 10.9 11.4
Partial thromboplastin time
 (sec)
22.1 28.0
IgE (kU/l) 62.1 <100
Table1. Results of blood tests and ascitic fluid 
analysis
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The patient was admitted to our unit and microbiological, mycobacteriological and cytological studies of ascitic fluid were requested. Blood 
cultures, and microbiological and parasitological stool samples were collected and ceftriaxone 2 g IV was initiated.
The patient’s symptoms and ascites worsened. In light of the clinical findings, ascites with SAG <1.1, peripheral eosinophilia and the 
imaging results, the differential diagnosis included gastrointestinal tract neoplasia and parasitic infections. Cytological analysis of ascitic 
fluid revealed inflammatory characteristics with a predominance of eosinophils but with no evidence of malignancy (Fig. 2). Upper and 
lower digestive endoscopy was normal. A biopsy of the pancreas was performed but there was no evidence of malignancy on histological 
examination. All microbiological studies including parasitological analysis of the faeces and serology for parasites were negative. Auto-
antibodies to coeliac disease and an autoimmune study were also negative (Table 1).
Since all studies were negative, eosinophilic gastroenteritis was considered. Upper gastrointestinal endoscopy was repeated and gastric 
and jejunal biopsy specimens were normal. Due to the absence of eosinophil infiltration in the biopsy specimens, paracentesis was repeated 
and the predominance of eosinophils in the ascitic fluid was confirmed, a distinct finding compared with the initial automated analysis that 
showed 75% of neutrophils, known to be a mistake after discussion with laboratory technicians. The diagnosis of eosinophilic gastroenteritis 
was made and, given the clinical worsening, corticosteroid therapy with prednisolone 40 mg/day was started. There was improvement 
and complete resolution of all symptomatology, ascites and negative analysis findings after 2 months. During follow-up consultation after 
corticosteroid withdrawal, clinical relapse was observed, so corticosteroid therapy was reinstated. The patient is currently corticosteroid-
dependent on a daily dose of 5 mg prednisolone.
DISCUSSION
Eosinophilic gastroenteritis is an uncommon disease but the diagnosis should be considered in the presence of gastrointestinal symptoms or 
ascites associated with peripheral eosinophilia (>500 eosinophils/µl). The definitive diagnosis is established in the presence of eosinophilic 
infiltration of the gastrointestinal tract or ascites with a predominance of eosinophils[2]. It is mandatory to exclude differential diagnoses[2], 
namely neoplasms, parasitic infections, inflammatory bowel disease, vasculitis, Langerhans cell histiocytosis and hypereosinophilic 
syndrome. In our patient, the analytical, microbiological and anatomopathological studies excluded most of the differential diagnoses, 
leaving hypereosinophilic syndrome which should always be considered in the presence of eosinophilia. This syndrome is characterized 
by a peripheral eosinophil count above 1,500/µl for at least 6 months and the involvement of other organs, which was not observed in this 
particular case.
Figure 1. Abdominal computed axial tomography showing ascites and gastric 
wall thickening
Figure 2. Histological examination of ascitic fluid showing abundant cellularity 
with inflammatory characteristics with a predominance of eosinophils (40× 
magnification)
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Eosinophilic infiltration is confirmed through multiple gastric and intestinal biopsies as one is not sufficient[3]. Diagnosis by biopsy is possible 
in 80% of patients[3]. However, in isolated muscle or subserous disease, biopsies may be normal[1], which explains the absence of eosinophils 
in the biopsy performed in the present case, supporting the diagnostic hypothesis of isolated subserous disease.
Spontaneous remission of disease is rare. The scientific evidence regarding treatment is limited, but it is mentioned that the initial approach 
depends on the severity of the symptomatology. In the initial phase an elemental diet should be tried[2]. In the absence of response to dietary 
changes or in the presence of severe symptomatology, corticosteroid therapy should be considered. Three types of response to therapy are 
described: (a) complete remission; (b) complete or partial remission in the initial phase but with sporadic flares of disease between months 
to years apart requiring transient introduction of or increased corticosteroid therapy; and (c) lack of response with a sustained need for low-
dose corticosteroids. The recommended dosage in the acute phase is daily 20–40 mg prednisolone and improvement is usually seen within 
2 weeks[4]. After resolution of symptomatology, corticosteroid therapy should be reduced to the lowest possible dose with the objective of 
complete suspension.
